Therapeutic plasma exchange does not reduce vasopressor requirement in severe acute liver failure: A retrospective case series

Ubbo F. Wiersema, Susan W. Kim, David Roxby, Andrew Holt

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: In acute liver failure (ALF) therapeutic plasma exchange (TPE) improves laboratory measures of liver function. In patients with ALF requiring minimal vasoactive support TPE has also been shown to provide haemodynamic benefits including an increase in systemic blood pressure. However the haemodynamic effects of TPE in patients with severe ALF requiring moderate or high dose vasopressor therapy has not been reported. We retrospectively examined the haemodynamic effects of TPE in a cohort of patients with severe ALF requiring vasopressor therapy. Methods: Physiological, laboratory and treatment data were collected on all patients with ALF who received TPE between January 2000 and December 2012. All patients were managed in the intensive care unit of a tertiary referral centre for ALF and liver transplantation. The primary outcome measures were changes in mean arterial pressure (MAP), vasopressor score and the ratio of vasopressor score to MAP (vasopressor dependency index (VDI)) from baseline prior to TPE through to 12 hours after completion of TPE. Secondary outcome measures were changes in other routinely collected physiological variables and laboratory results. Results are presented as median (interquartile range (IQR)). Outcome measures were evaluated using a mixed effect model. Results: Thirty nine TPE were performed in 17 patients with ALF (13 paracetamol poisoning). All TPE were performed with a centrifugal apheresis system (duration 130 minutes (IQR 115 - 147.5), plasma volume removed 5.1% body weight (IQR 4.6 - 5.5). Baseline values for primary outcome measures were: MAP 82 mmHg (IQR 72 - 92.5), vasopressor score 8.35 (IQR 3.62 - 24.6) and VDI 0.10 (IQR 0.05 - 0.31). MAP was significantly higher immediately after TPE compared to baseline (p = 0.039), however when corrected for change in vasopressor requirement there was no significant change in VDI with TPE (p = 0.953). Twelve hours after TPE the MAP, vasopressor score and VDI were not significantly different from baseline (p = 0.563, p = 0.317 and p = 0.214 respectively). Conclusion: In this cohort of patients with severe ALF centrifugal TPE did not significantly affect vasopressor requirements.

LanguageEnglish
Article number30
JournalBMC Anesthesiology
Volume15
Issue number1
DOIs
Publication statusPublished - 8 Mar 2015

Keywords

  • Acute liver failure
  • Haemodynamic
  • Plasmapheresis
  • Shock
  • Therapeutic plasma exchange
  • Vasopressor

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Wiersema, Ubbo F. ; Kim, Susan W. ; Roxby, David ; Holt, Andrew. / Therapeutic plasma exchange does not reduce vasopressor requirement in severe acute liver failure : A retrospective case series. In: BMC Anesthesiology. 2015 ; Vol. 15, No. 1.
@article{00569abcb2d2459a8657533a59adf87f,
title = "Therapeutic plasma exchange does not reduce vasopressor requirement in severe acute liver failure: A retrospective case series",
abstract = "Background: In acute liver failure (ALF) therapeutic plasma exchange (TPE) improves laboratory measures of liver function. In patients with ALF requiring minimal vasoactive support TPE has also been shown to provide haemodynamic benefits including an increase in systemic blood pressure. However the haemodynamic effects of TPE in patients with severe ALF requiring moderate or high dose vasopressor therapy has not been reported. We retrospectively examined the haemodynamic effects of TPE in a cohort of patients with severe ALF requiring vasopressor therapy. Methods: Physiological, laboratory and treatment data were collected on all patients with ALF who received TPE between January 2000 and December 2012. All patients were managed in the intensive care unit of a tertiary referral centre for ALF and liver transplantation. The primary outcome measures were changes in mean arterial pressure (MAP), vasopressor score and the ratio of vasopressor score to MAP (vasopressor dependency index (VDI)) from baseline prior to TPE through to 12 hours after completion of TPE. Secondary outcome measures were changes in other routinely collected physiological variables and laboratory results. Results are presented as median (interquartile range (IQR)). Outcome measures were evaluated using a mixed effect model. Results: Thirty nine TPE were performed in 17 patients with ALF (13 paracetamol poisoning). All TPE were performed with a centrifugal apheresis system (duration 130 minutes (IQR 115 - 147.5), plasma volume removed 5.1{\%} body weight (IQR 4.6 - 5.5). Baseline values for primary outcome measures were: MAP 82 mmHg (IQR 72 - 92.5), vasopressor score 8.35 (IQR 3.62 - 24.6) and VDI 0.10 (IQR 0.05 - 0.31). MAP was significantly higher immediately after TPE compared to baseline (p = 0.039), however when corrected for change in vasopressor requirement there was no significant change in VDI with TPE (p = 0.953). Twelve hours after TPE the MAP, vasopressor score and VDI were not significantly different from baseline (p = 0.563, p = 0.317 and p = 0.214 respectively). Conclusion: In this cohort of patients with severe ALF centrifugal TPE did not significantly affect vasopressor requirements.",
keywords = "Acute liver failure, Haemodynamic, Plasmapheresis, Shock, Therapeutic plasma exchange, Vasopressor",
author = "Wiersema, {Ubbo F.} and Kim, {Susan W.} and David Roxby and Andrew Holt",
year = "2015",
month = "3",
day = "8",
doi = "10.1186/s12871-015-0017-9",
language = "English",
volume = "15",
journal = "BMC Anesthesiology",
issn = "1471-2253",
publisher = "BioMed Central",
number = "1",

}

Therapeutic plasma exchange does not reduce vasopressor requirement in severe acute liver failure : A retrospective case series. / Wiersema, Ubbo F.; Kim, Susan W.; Roxby, David; Holt, Andrew.

In: BMC Anesthesiology, Vol. 15, No. 1, 30, 08.03.2015.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Therapeutic plasma exchange does not reduce vasopressor requirement in severe acute liver failure

T2 - BMC Anesthesiology

AU - Wiersema, Ubbo F.

AU - Kim, Susan W.

AU - Roxby, David

AU - Holt, Andrew

PY - 2015/3/8

Y1 - 2015/3/8

N2 - Background: In acute liver failure (ALF) therapeutic plasma exchange (TPE) improves laboratory measures of liver function. In patients with ALF requiring minimal vasoactive support TPE has also been shown to provide haemodynamic benefits including an increase in systemic blood pressure. However the haemodynamic effects of TPE in patients with severe ALF requiring moderate or high dose vasopressor therapy has not been reported. We retrospectively examined the haemodynamic effects of TPE in a cohort of patients with severe ALF requiring vasopressor therapy. Methods: Physiological, laboratory and treatment data were collected on all patients with ALF who received TPE between January 2000 and December 2012. All patients were managed in the intensive care unit of a tertiary referral centre for ALF and liver transplantation. The primary outcome measures were changes in mean arterial pressure (MAP), vasopressor score and the ratio of vasopressor score to MAP (vasopressor dependency index (VDI)) from baseline prior to TPE through to 12 hours after completion of TPE. Secondary outcome measures were changes in other routinely collected physiological variables and laboratory results. Results are presented as median (interquartile range (IQR)). Outcome measures were evaluated using a mixed effect model. Results: Thirty nine TPE were performed in 17 patients with ALF (13 paracetamol poisoning). All TPE were performed with a centrifugal apheresis system (duration 130 minutes (IQR 115 - 147.5), plasma volume removed 5.1% body weight (IQR 4.6 - 5.5). Baseline values for primary outcome measures were: MAP 82 mmHg (IQR 72 - 92.5), vasopressor score 8.35 (IQR 3.62 - 24.6) and VDI 0.10 (IQR 0.05 - 0.31). MAP was significantly higher immediately after TPE compared to baseline (p = 0.039), however when corrected for change in vasopressor requirement there was no significant change in VDI with TPE (p = 0.953). Twelve hours after TPE the MAP, vasopressor score and VDI were not significantly different from baseline (p = 0.563, p = 0.317 and p = 0.214 respectively). Conclusion: In this cohort of patients with severe ALF centrifugal TPE did not significantly affect vasopressor requirements.

AB - Background: In acute liver failure (ALF) therapeutic plasma exchange (TPE) improves laboratory measures of liver function. In patients with ALF requiring minimal vasoactive support TPE has also been shown to provide haemodynamic benefits including an increase in systemic blood pressure. However the haemodynamic effects of TPE in patients with severe ALF requiring moderate or high dose vasopressor therapy has not been reported. We retrospectively examined the haemodynamic effects of TPE in a cohort of patients with severe ALF requiring vasopressor therapy. Methods: Physiological, laboratory and treatment data were collected on all patients with ALF who received TPE between January 2000 and December 2012. All patients were managed in the intensive care unit of a tertiary referral centre for ALF and liver transplantation. The primary outcome measures were changes in mean arterial pressure (MAP), vasopressor score and the ratio of vasopressor score to MAP (vasopressor dependency index (VDI)) from baseline prior to TPE through to 12 hours after completion of TPE. Secondary outcome measures were changes in other routinely collected physiological variables and laboratory results. Results are presented as median (interquartile range (IQR)). Outcome measures were evaluated using a mixed effect model. Results: Thirty nine TPE were performed in 17 patients with ALF (13 paracetamol poisoning). All TPE were performed with a centrifugal apheresis system (duration 130 minutes (IQR 115 - 147.5), plasma volume removed 5.1% body weight (IQR 4.6 - 5.5). Baseline values for primary outcome measures were: MAP 82 mmHg (IQR 72 - 92.5), vasopressor score 8.35 (IQR 3.62 - 24.6) and VDI 0.10 (IQR 0.05 - 0.31). MAP was significantly higher immediately after TPE compared to baseline (p = 0.039), however when corrected for change in vasopressor requirement there was no significant change in VDI with TPE (p = 0.953). Twelve hours after TPE the MAP, vasopressor score and VDI were not significantly different from baseline (p = 0.563, p = 0.317 and p = 0.214 respectively). Conclusion: In this cohort of patients with severe ALF centrifugal TPE did not significantly affect vasopressor requirements.

KW - Acute liver failure

KW - Haemodynamic

KW - Plasmapheresis

KW - Shock

KW - Therapeutic plasma exchange

KW - Vasopressor

UR - http://www.scopus.com/inward/record.url?scp=84928725717&partnerID=8YFLogxK

U2 - 10.1186/s12871-015-0017-9

DO - 10.1186/s12871-015-0017-9

M3 - Article

VL - 15

JO - BMC Anesthesiology

JF - BMC Anesthesiology

SN - 1471-2253

IS - 1

M1 - 30

ER -